Webbplatsen kommer inte fungerar helt korrekt om er webbläsares JavaScript funktion är inaktiverad.
}
Tumour removal without surgical intervention

Resitu

Resitu Medical is developing a patented instrument for medical biopsies, which can quickly remove pieces of tissue in case of suspected breast cancer, with only local anesthesia and with minimal risk of bleeding. Since the entire tumor is removed already in the biopsy stage, no further surgery is needed.

Resitu

CEO:

Stefan Sowa

First investment year:

2021

Business sector:

Life Science, Medtech

Investment manager: Maria Tell Visit website